about
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipientsPaving the way for predictive diagnostics and personalized treatment of invasive aspergillosisIL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasisGenetic Variation in Autophagy-Related Genes Influences the Risk and Phenotype of Buruli UlcerDectin-1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis.Impact of Paracoccin Gene Silencing on Paracoccidioides brasiliensis Virulence.The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferationTLR9 activation dampens the early inflammatory response to Paracoccidioides brasiliensis, impacting host survival.Human genetic susceptibility to invasive aspergillosis.CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.DAMP signaling in fungal infections and diseases.Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium.Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVCCommon Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisThe soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphomaImmunometabolic Pathways in BCG-Induced Trained Immunity.Genetic variability of innate immunity impacts human susceptibility to fungal diseases.Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO.Cracking the Toll-like receptor code in fungal infections.Immunity and tolerance to infections in experimental hematopoietic transplantation.Immunogenetic profiling to predict risk of invasive fungal diseases: where are we now?Immunotherapy of aspergillosis.Neutrophil responses to aspergillosis: new roles for old players.The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases.Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity.The Cell Biology of the Trichosporon-Host Interaction.Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.Towards a molecular genetic system for the pathogenic fungus Paracoccidioides brasiliensis.IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity.Host-Derived Biomarkers for Risk Assessment of Invasive Fungal Diseases.Immunity and tolerance to fungi in hematopoietic transplantation: principles and perspectives.Host defense pathways against fungi: the basis for vaccines and immunotherapy.Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis.Inflammation in aspergillosis: the good, the bad, and the therapeutic.Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation.Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.
P50
Q27312010-EF165698-4F17-48CF-AACB-03C064BF7FDDQ28081259-A282D37E-5622-430C-949E-076158A1C1D3Q28534626-A835F45E-95A7-4C8D-AE7D-297596F72017Q28551704-AB74D996-B146-4E01-B130-E0F0C2049E5AQ33577398-C73DE0C8-1B64-4C80-AAD7-97B6A96447CBQ33916454-27B60273-E159-4C9A-AFFF-C9E790D5D5E4Q34088209-42EF2804-9B69-4F45-A17B-C847D8ABD6EFQ34927375-DB4B2FC6-0DEB-40BD-97EC-66580B7A17A4Q34945368-9FDEF082-7E59-4B3D-9705-7D4349E245D5Q35913715-299D6204-9EB8-49EC-876A-C1659B947D3DQ36220396-334671D5-FBE3-47AC-9418-30A370AB73A6Q36631361-A000D5BB-408B-413D-803D-8DE1EAC97851Q36823742-29D156E5-9844-4DE3-A355-E03FCDF09DB7Q37169890-CE8D2E82-7161-4DBB-AE7D-ACC14872B0D4Q37272060-A5AA0F06-A743-404B-8681-792F274D80FAQ37422510-C1CC92B0-8EEC-4917-BFAF-661A13397B78Q37525436-8EC5848C-1FA6-4C20-BAC6-A4ADAABAF69EQ37614655-25AC8214-BEE8-4E8D-B60F-AC0E06EDBAD0Q37729196-7631B7A7-6750-4285-B45D-6685B8581E5EQ37800920-1B80B63F-52AE-46A1-AF34-CEB6CB0A0557Q37933842-13B33C9A-FFB4-457B-801A-0A5DC946636AQ37943845-1FD9B824-3102-4BE3-AAEF-FD5AA4FB6CD7Q37949009-C72AFF43-C127-4ED6-B258-A7A90BF6963AQ38238256-914A0560-2342-40CC-B40F-AD56D0CDE911Q39001907-CC347BEE-23EA-4248-A1D4-7EBD4EEB2CDCQ39170824-49B049F5-3E4E-4879-A52E-7B59887EB303Q39260239-BEA5F1E5-39FC-43ED-85C9-E08CCAE4D048Q39488014-AF3EB568-5EF3-4AA9-8E51-AA6C45852B2EQ40211743-EC8340CF-6308-41DA-9CA8-3B6D53A48EF1Q40259962-4CAB1149-62DD-4BDE-B51F-E67437781ABEQ40454869-134E67BA-B88A-4503-8383-B6C94069F6F5Q41825799-70F8DEA8-7F1D-4C0C-9DEF-42E05F16CAACQ41901935-3AA80FAF-09F8-4C36-8946-9C86197E59EFQ42230664-2B0C968C-7550-46FA-8CE6-C362BAFAF097Q42289900-4B4D42DE-70A7-47CE-A257-9FE55D0D218EQ43239054-85E464BC-480D-459F-A9C2-F5F6C6BB6ED2Q44902285-842247B5-83EE-4394-811C-B86F9B23DB9AQ44909879-144A29C2-C78E-47A6-B7EC-A0C0C568C9CAQ45210371-0B217FDB-BB12-4FEC-8F57-F0BFAB454EE9Q45760347-E60ABF59-F6AA-46F6-A751-E4DF5C47730F
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristina Cunha
@ast
Cristina Cunha
@en
Cristina Cunha
@es
Cristina Cunha
@nl
Cristina Cunha
@sl
type
label
Cristina Cunha
@ast
Cristina Cunha
@en
Cristina Cunha
@es
Cristina Cunha
@nl
Cristina Cunha
@sl
prefLabel
Cristina Cunha
@ast
Cristina Cunha
@en
Cristina Cunha
@es
Cristina Cunha
@nl
Cristina Cunha
@sl
P1053
D-2687-2009
P106
P1153
57097771800
P21
P31
P3829
P496
0000-0002-6002-5782